Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer (Nature Cancer, (2022), 3, 8, (927-931), 10.1038/s43018-022-00400-2)

Laura M. Spring, Hyo Han, Minetta C. Liu, Erika Hamilton, Hanna Irie, Cesar A. Santa-Maria, James Reeves, Peng Pan, Ming Shan, Yongqiang Tang, Julie R. Graham, Sebastien Hazard, Leif W. Ellisen, Steven J. Isakoff

Research output: Contribution to journal › Comment/debate

Fingerprint

Dive into the research topics of 'Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer (Nature Cancer, (2022), 3, 8, (927-931), 10.1038/s43018-022-00400-2)'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry